Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Omnicell appoints new community pharmacy division leader

Omnicell appoints new community pharmacy division leader

Dedicated specialist teams developed to better deliver on the needs of community pharmacists 

American healthcare technology company Omnicell has appointed Edward Platt as the new Senior Commercial Director of its UK community pharmacy division.


Along with this new role, Edward, who joined Omnicell in 2015, will continue his current leadership remit for Omnicell’s UK & Ireland hospital division.

He will be leading a revamped commercial team, which would be responsible for increasing Omnicell’s footprint of automation and consumable solutions delivered into UK community pharmacies.

As part of the revamp, the company has created dedicated specialist teams to ensure the needs and challenges of community pharmacists (small independents and small multiple operators) can be fully understood and supported.

Edward said: “Faced with funding cuts, staff shortages, rising costs, increased demand and the continuing growth of mail-order pharmacies, community pharmacists are facing a myriad of challenges just to survive.

“Community pharmacies need to make tangible change to their operating models, and we see the adoption of automation as key in helping them evolve into sustainable and successful businesses. With our new and repurposed team, we are fully committed to supporting community pharmacists and helping them to realise the benefits of harnessing technology,” he added.

Kath Hughes, who has 25 years of experience in supplying solutions into the healthcare sector, has been appointed as Senior National Sales Manager, and she will be managing Omnicell’s national chains and buying group relationships.

Tariq Hussain, who brings more than 20 years of experience in supplying pharmacy automation and pharmaceuticals to community pharmacy, will be responsible for the company’s major multiple operators as National Strategic Account Manager.

Additionally, three new Regional Sales Managers have been appointed to ­­­­­­­­support the needs of more than 400 small multiple pharmacy businesses, and two people to focus on supporting the needs of small independent pharmacies.

Omnicell is a leading provider of medication management solutions and adherence tools for health systems and pharmacies.  They company recently managed the 200th UK installation of their market-leading Pharmaself24 prescription collection kiosk.

More For You

Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less